Viral targets for vaccines against COVID-19

Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19) pandemic and to help the return to pre-pandemic normalcy. A great many vaccine candidates are being developed, several of which have completed late-stage clinical trials and are reporting positive results. In this Progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Lianpan, Gao, George F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Progress
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747004/
https://www.ncbi.nlm.nih.gov/pubmed/33340022
http://dx.doi.org/10.1038/s41577-020-00480-0
_version_ 1783624907629789184
author Dai, Lianpan
Gao, George F.
author_facet Dai, Lianpan
Gao, George F.
author_sort Dai, Lianpan
collection PubMed
description Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19) pandemic and to help the return to pre-pandemic normalcy. A great many vaccine candidates are being developed, several of which have completed late-stage clinical trials and are reporting positive results. In this Progress article, we discuss which viral elements are used in COVID-19 vaccine candidates, why they might act as good targets for the immune system and the implications for protective immunity.
format Online
Article
Text
id pubmed-7747004
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-77470042020-12-18 Viral targets for vaccines against COVID-19 Dai, Lianpan Gao, George F. Nat Rev Immunol Progress Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19) pandemic and to help the return to pre-pandemic normalcy. A great many vaccine candidates are being developed, several of which have completed late-stage clinical trials and are reporting positive results. In this Progress article, we discuss which viral elements are used in COVID-19 vaccine candidates, why they might act as good targets for the immune system and the implications for protective immunity. Nature Publishing Group UK 2020-12-18 2021 /pmc/articles/PMC7747004/ /pubmed/33340022 http://dx.doi.org/10.1038/s41577-020-00480-0 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Progress
Dai, Lianpan
Gao, George F.
Viral targets for vaccines against COVID-19
title Viral targets for vaccines against COVID-19
title_full Viral targets for vaccines against COVID-19
title_fullStr Viral targets for vaccines against COVID-19
title_full_unstemmed Viral targets for vaccines against COVID-19
title_short Viral targets for vaccines against COVID-19
title_sort viral targets for vaccines against covid-19
topic Progress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747004/
https://www.ncbi.nlm.nih.gov/pubmed/33340022
http://dx.doi.org/10.1038/s41577-020-00480-0
work_keys_str_mv AT dailianpan viraltargetsforvaccinesagainstcovid19
AT gaogeorgef viraltargetsforvaccinesagainstcovid19

Ejemplares similares